Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 71
Filtrar
1.
J Environ Radioact ; 270: 107282, 2023 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-37619406

RESUMEN

Fish in lakes situated within the Chornobyl exclusion zone have been highly contaminated since the accident and have not been utilized as food for humans. In the present study, field experiments with less-contaminated silver Prussian carp (Carassius gibelio (Bloch, 1782)) caged in contaminated lake within the Chornobyl exclusion zone was performed from June to October 2021 to investigate the effectiveness of clean feed containing potassium ferric hexacyanoferrate (KFCF) KFe[Fe(CN)6], a kind of Prussian Blue as a countermeasure to reduce 137Cs accumulation in fish. The addition of clean feed containing 0.1% or 1% KFCF resulted respectively in 2.4 ± 0.4 or 4.2 ± 0.7 times lower activity concentration of 137Cs in muscle tissue of the carp compared to control fish with clean feed without KFCF and in 7-16 or 12-27 times lower activities compared to fish without additional clean feeding. After 18 weeks exposure, 137Cs levels in all the caged fish except for the control group were below the European permissible level (600 Bq kg-1) for consumption. In contrast, KFCF did not affect the intake of 90Sr in fish, although additional feed increased the growth rate and thereby accumulation in bone tissues. Hence, the use of clean feed containing KFCF is judged to be an effective and inexpensive countermeasure to reduce the 137Cs contamination of edible fish muscles.


Asunto(s)
Accidente Nuclear de Chernóbil , Monitoreo de Radiación , Animales , Humanos , Lagos , Peces
2.
Eur J Paediatr Neurol ; 23(4): 629-638, 2019 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-31085021

RESUMEN

PURPOSE: The modified Atkins diet (MAD) is a less restrictive treatment option than the ketogenic diet (KD) for intractable epilepsy and some metabolic conditions. Prolonged KD treatment may decrease bone mineralization and affect linear growth; however, long-term studies of MAD treatment are lacking. This study was designed to assess growth, body composition, and bone mass in children on MAD treatment for 24 months. METHODS: Thirty-eight patients, mean age (SD) 6.1 years (4.8 years), 21 girls, with intractable epilepsy (n = 22), glucose transporter type 1 deficiency syndrome (n = 7), or pyruvate dehydrogenase complex deficiency (n = 9) were included. Body weight, height, body mass index (BMI), bone mass, and laboratory tests (calcium, phosphorus, magnesium, alkaline phosphatase, cholesterol, 25-hydroxyvitamin D, insulin-like growth factor-I and insulin-like growth factor binding protein 3) were assessed at baseline and after 24 months of MAD treatment. RESULTS: Approximately 50% of the patients responded with more than 50% seizure reduction. Weight and height standard deviation score (SDS) were stable over 24 months, whereas median (minimum - maximum) BMI SDS increased from 0.2 (-3.3 to 4.5) to 0.7 (-0.9 to 2.6), p < 0.005. No effects were observed for bone mass (total body, lumbar spine and hip) or fat mass. CONCLUSIONS: The MAD was efficient in reducing seizures, and no negative effect was observed on longitudinal growth or bone mass after MAD treatment for 24 months.


Asunto(s)
Dieta Rica en Proteínas y Pobre en Hidratos de Carbono/métodos , Epilepsia Refractaria/dietoterapia , Adolescente , Densidad Ósea , Niño , Preescolar , Femenino , Humanos , Lactante , Estudios Longitudinales , Masculino , Estudios Prospectivos , Suecia , Resultado del Tratamiento
3.
Horm Metab Res ; 48(10): 664-672, 2016 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-27579526

RESUMEN

Patients with anorexia nervosa (AN) are at high risk of reduced bone mass. Osteocalcin (OC), a bone formation marker, has been proposed to act as a link between bone and energy metabolism. We investigated how the 3 forms of OC respond during a 12-week intensive nutrition therapy in AN patients, in whom large changes in energy metabolism are expected.Twenty-two female AN patients, mean 20.9 years of age, with a starting mean body mass index (BMI) 15.5 kg/m2 (minimum-maximum) (13.4-17.3 kg/m2) completed the study. Biochemical markers, body composition, bone mass by DXA, and pQCT were assessed. Subjects gained in median 9.9 kg (5.5-17.0 kg), and BMI increased from median 15.4 kg/m2 (13.4-17.3 kg/m2) to 19.0 kg/m2 (16.2-20.6 kg/m2), p<0.0001. Fat mass increased from median 11.4% (4.4-24.8%) to 26.7% (16.9-39.8%). Total OC, carboxylated OC (cOC), undercarboxylated OC (ucOC), and bone-specific alkaline phosphatase (BALP) increased during the study period. No change was observed for the resorption marker carboxy-terminal cross-linking telopeptide of type I collagen (CTX). Total body bone mineral content (BMC) increased, but no changes were found for whole body or lumbar spine bone mineral density. Tibial trabecular density measured by pQCT decreased. Total OC, cOC, and ucOC were not associated with BMI, insulin or body composition parameters. This prospective study demonstrates that all 3 forms of OC (total OC, cOC, ucOC) increase during rapid weight gain. BALP increased while the resorption marker CTX was unchanged, which corroborate with the increased total body BMC.


Asunto(s)
Anorexia Nerviosa/rehabilitación , Biomarcadores/sangre , Densidad Ósea , Remodelación Ósea/fisiología , Aumento de Peso , Adolescente , Adulto , Anorexia Nerviosa/sangre , Anorexia Nerviosa/dietoterapia , Composición Corporal , Femenino , Estudios de Seguimiento , Humanos , Masculino , Pronóstico , Estudios Prospectivos , Adulto Joven
4.
J Endocrinol Invest ; 38(12): 1309-17, 2015 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-26253710

RESUMEN

PURPOSE: This study investigated the relationship between seasonal variations in 25-hydroxyvitamin D (25(OH)D) levels and growth in prepubertal children during both the pretreatment year and the first year of GH treatment. METHODS: The study included 249 short prepubertal children with a broad range of GH secretion, GH(max) during a 24 h profile median 23; range 1-127 mU/L, 191 boys (mean age ± SD, 8.6 ± 2.6 years), 58 girls (7.5 ± 1.9 years) receiving GH treatment (mean 43 µg/kg/day; range 17-99 µg/kg/day). Serum 25(OH)D was measured using an automated IDS-iSYS immunoassay. RESULTS: 25(OH)D levels showed seasonal variation, and decreased significantly during GH treatment. 25(OH)D levels at start and first year reduction in 25(OH)D, correlated (-) with the first year growth response during treatment. The degree of GH secretion capacity within our study population of mainly non-GH deficient children and 25(OH)D sufficient (67 ± 29 nmol/L) had no influence on 25(OH)D levels. Growth during GH treatment were independent of seasonal variations in 25(OH)D. Multiple regression analysis showed that 25(OH)D levels at treatment start, together with auxological data and IGF-binding protein-(3)SDS, explained 61 % of the variation in first year gain in heightSDS. CONCLUSION: 25(OH)D levels were associated with first year growth response to GH and may be a useful contribution to future growth prediction models.


Asunto(s)
Trastornos del Crecimiento/sangre , Trastornos del Crecimiento/tratamiento farmacológico , Hormona del Crecimiento/farmacología , Evaluación de Resultado en la Atención de Salud , Estaciones del Año , Vitamina D/análogos & derivados , Niño , Femenino , Hormona del Crecimiento/administración & dosificación , Humanos , Masculino , Vitamina D/sangre
5.
J Musculoskelet Neuronal Interact ; 13(1): 13-8, 2013 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-23445910

RESUMEN

OBJECTIVES: To study the tolerability of whole body vibration (WBV) exercise in patients with Duchenne muscular dystrophy (DMD) and its effects on muscle and bone. METHODS: WBV was performed two to three times a week for three months. Motor function, muscle strength, bone mass and biochemical markers of bone and mineral metabolism were analyzed before and after the WBV period at 0, 3, 6 and 12 months. RESULTS: Six ambulatory patients with DMD aged 5.7-12.5 years completed the study. No changes in creatine kinase activity were found, indicating that the WBV exercise did not further damage the skeletal muscle. No significant changes in bone mass, muscle strength or bone markers were found. However, there was a non-significant trend for the bone formation marker, bone-specific alkaline phosphate, to increase from a mean of 59 U/L to 73 U/L after three months of WBV. The bone formation marker levels returned to baseline three months after discontinuing WBV and were still at that level after nine months. CONCLUSIONS: WBV therapy appears to be safe and well tolerated among ambulatory DMD patients. The potential benefits of WBV on bone and muscle in DMD remain to be elucidated.


Asunto(s)
Distrofia Muscular de Duchenne/fisiopatología , Distrofia Muscular de Duchenne/terapia , Vibración/uso terapéutico , Densidad Ósea/fisiología , Preescolar , Estudios de Seguimiento , Humanos , Masculino , Fuerza Muscular/fisiología , Músculo Esquelético/fisiología , Distrofia Muscular de Duchenne/diagnóstico , Estudios Prospectivos
6.
Int J Obes (Lond) ; 35 Suppl 1: S119-24, 2011 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-21483411

RESUMEN

OBJECTIVE: To investigate the relationship between bone mineral density (BMD), anthropometric characteristics, levels of biological markers for growth, bone turnover, insulin resistance and fat mass in 4-year-old Swedish children. METHODS: Descriptive study with 41 children (28 boys) who had anthropometric measurements and blood samples taken and heel dual-energy X-ray absorptiometry and laser (DXL) performed. The study participants were divided into groups of normal-weight (n=28) and overweight or obese (n=13) children. RESULTS: There was a significant difference in bone mineral content (BMC), BMD and bone mineral apparent density (BMAD) between overweight and normal-weight children. There was a significant positive correlation between BMC, BMD, BMAD and body mass index standard deviation scores (r=0.36, 0.34 and 0.29, P<0.01, respectively), waist circumference (r=0.32, 0.30, P<0.01 and r=0.26, P<0.05, respectively) and subscapular skinfold (r=0.26, 0.25 and 0.23, P<0.05, respectively). BMC and BMD correlated significantly with the sum of skinfold measures (r=0.25 and 0.23, P<0.05, respectively). Adiponectin was significantly inversely correlated with BMC, BMD and BMAD (r=-0.41, -0.40 and -0.41, P<0.01, respectively). Adiponectin was not correlated with skinfold measures. Multiple regression analysis revealed that adiponectin was an independent determinant of BMD, BMC and BMAD. CONCLUSION: To our knowledge, this is the first study investigating BMD assessed by heel-DXL in relation to anthropometry and metabolic markers in 4-year-old children. Adiponectin was significantly inversely correlated with bone mass parameters. Adiponectin may have an independent role in bone development and metabolism in young children.


Asunto(s)
Absorciometría de Fotón/métodos , Adiponectina/sangre , Densidad Ósea/fisiología , Resistencia a la Insulina/fisiología , Obesidad/sangre , Antropometría , Biomarcadores/sangre , Índice de Masa Corporal , Niño , Preescolar , Dieta , Femenino , Humanos , Estilo de Vida , Masculino , Obesidad/fisiopatología , Proyectos Piloto
7.
Int J Obes (Lond) ; 35 Suppl 1: S125-30, 2011 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-21483412

RESUMEN

BACKGROUND: Quantitative ultrasound (QUS) is a quick, non-invasive and inexpensive method to measure bone strength. Moreover, the device is portable, which makes it easy to be used in the field. In contrast to other bone measuring techniques, QUS does not use any ionised radiation. However, the validity of QUS in the measurement of bone health and the relationship between QUS output and body composition have not been assessed in very young children. OBJECTIVE: To investigate the relationship between paediatric calcaneal QUS and both dual-energy X-ray absorptiometry (DXA) and calcaneal DXA with laser (DXL) and body composition parameters. SUBJECTS: A total of 37 Belgian children (10 boys and 27 girls; 4 to 8 years old) underwent a calcaneal QUS as well as a DXA scan. A total of 24 Swedish children (15 boys and 9 girls; 3 to 5 years old) underwent a calcaneal QUS as well as a heel DXL scan. The height and weight of all children were measured. RESULTS: The QUS stiffness index (SI) was significantly negatively correlated with bone mineral density (BMD) of the total body (r=-0.370, P=0.02). No significant correlations were found between the SI and DXL results. In the total sample, the SI showed a significant positive correlation with body mass index (BMI) (r=0.298, P=0.02), even after correction for age, gender and centre. In the Belgian sample, the SI was also significantly positively correlated with total body fat mass content (r=0.416, P=0.01) and body fat percentage (r=0.566, P<0.01) obtained by whole-body DXA. CONCLUSION: The SI measured by QUS does not correlate significantly with BMD values measured by DXA or DXL in 3- to 8-year-old children. However, there is a significant positive correlation between SI and BMI and body fat %.


Asunto(s)
Absorciometría de Fotón/métodos , Densidad Ósea/fisiología , Calcáneo/diagnóstico por imagen , Osteoporosis/diagnóstico , Tejido Adiposo/diagnóstico por imagen , Bélgica , Composición Corporal/fisiología , Índice de Masa Corporal , Niño , Preescolar , Femenino , Humanos , Masculino , Osteoporosis/diagnóstico por imagen , Osteoporosis/prevención & control , Cintigrafía , Ultrasonografía
9.
Br J Sports Med ; 42(3): 225-8; discussion 228, 2008 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-17717060

RESUMEN

OBJECTIVE: The number of calories expended in the workplace has declined significantly in the past 75 years. A walking workstation that allows workers to walk while they work has the potential to increase caloric expenditure. We evaluated whether employees can and will use walking workstations while performing their jobs. METHODS AND PROCEDURES: We studied nurses, clinical assistants, secretaries and appointment secretaries using the StepWatch Activity Monitor System (which accurately measures steps taken at slow speeds) while performing their job functions in their usual fashion and while using the walking workstation. RESULTS: Subjects increased the number of steps taken during the workday by 2000 steps per day (p<0.05). This was equivalent to an increase in caloric expenditure of 100 kcal/day. Subjects reported that they enjoyed using the workstation, that it could be used in the actual work arena and that, if available, they would use it. DISCUSSION: Walking workstations have the potential for promoting physical activity and facilitating weight loss. Several subjects in this study expended more than 200 extra calories daily using such a system. Further trials are indicated.


Asunto(s)
Empleo , Metabolismo Energético/fisiología , Caminata/fisiología , Actitud , Estudios de Factibilidad , Humanos , Lugar de Trabajo
10.
J Clin Densitom ; 8(3): 305-13, 2005.
Artículo en Inglés | MEDLINE | ID: mdl-16055961

RESUMEN

Dual-energy X-ray absorptiometry and laser (DXL) Calscan measures bone mineral density (BMD) in the calcaneus. In the present study, the DXL Calscan device has been modified for use in pediatric practice. It includes a function for measuring calcaneal height, which makes it possible to calculate volumetric bone mineral apparent density (BMAD). The aims of the present study were to evaluate the method when used in children, to create pediatric reference values in healthy Swedish 2-, 4-, and 7-yr-old children for BMD, bone mineral content (BMC), and BMAD, and to study whether these parameters were related to auxological data. The method was well tolerated by all children. Intraindividual coefficients of variation for BMC and BMD decreased with increasing age. The mean BMD was 0.17+/-0.003 g/cm2 in 2-yr-old children, 0.22+/-0.003 g/cm2 in 4-yr-old children, and 0.30+/-0.005 g/cm2 in 7-yr-old children. This study provides normative data as percentile values for BMD, BMC, and BMAD in young children measured with DXL Calscan. BMD was significantly correlated with age (p<0.001), height (p=0.001), weight (p<0.001), and body mass index standard deviation score (p<0.001). Seven-year-old girls showed significantly higher BMD than boys.


Asunto(s)
Absorciometría de Fotón/métodos , Envejecimiento/fisiología , Densidad Ósea/fisiología , Calcáneo/diagnóstico por imagen , Rayos Láser , Calcáneo/crecimiento & desarrollo , Niño , Preescolar , Estudios Transversales , Femenino , Humanos , Lactante , Masculino , Estándares de Referencia , Valores de Referencia
11.
J Clin Endocrinol Metab ; 89(10): 5156-60, 2004 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-15472220

RESUMEN

Both GH and IGF-I stimulate bone growth, but the molecular mechanisms mediating their effects on the growth plate are not fully understood. We measured gene expression by microarray analysis in primary cultured human chondrocytes treated with either GH or IGF-I. One of the genes found to be up-regulated by both GH and IGF-I was that encoding cartilage oligomeric matrix protein (COMP). This protein is predominantly found in the extracellular matrix of cartilage. Mutations in the COMP gene have been associated with syndromes of short stature. To verify that COMP is regulated by GH in vivo, we measured COMP levels in serum in short children treated with GH. The study included 113 short prepubertal children (14 girls and 99 boys) with a mean (+/- sd) age of 8.84 +/- 2.76 yr, height sd score of -2.74 +/- 0.67, and IGF-I sd score of -1.21 +/- 1.07 at the start of GH administration. Serum levels of COMP were 1.58 +/- 0.28, 1.83 +/- 0.28 (P < 0.0001), 1.91 +/- 0.28 (P < 0.0001), 1.78 +/- 0.28 (P < 0.001), and 1.70 +/- 0.24 (P < 0.05) microg/ml at baseline and after 1 wk and 1, 3, and 12 months, respectively. In conclusion, we have demonstrated that COMP expression is up-regulated by both GH and IGF-I in primary cultured human chondrocytes. Furthermore, serum levels of COMP increase after the start of GH treatment in short children.


Asunto(s)
Condrocitos/efectos de los fármacos , Proteínas de la Matriz Extracelular/sangre , Proteínas de la Matriz Extracelular/genética , Glicoproteínas/sangre , Glicoproteínas/genética , Trastornos del Crecimiento/tratamiento farmacológico , Hormona de Crecimiento Humana/administración & dosificación , Estatura , Proteína de la Matriz Oligomérica del Cartílago , Células Cultivadas , Niño , Preescolar , Condrocitos/citología , Condrocitos/fisiología , Femenino , Expresión Génica/efectos de los fármacos , Trastornos del Crecimiento/sangre , Humanos , Lactante , Factor I del Crecimiento Similar a la Insulina/farmacología , Masculino , Proteínas Matrilinas , Análisis de Secuencia por Matrices de Oligonucleótidos
12.
J Endocrinol ; 176(1): 13-21, 2003 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-12525245

RESUMEN

Leptin is involved in regulating food intake, energy balance and bone formation. Increasing evidence suggests that leptin is also involved in fetal growth and development. The aim of this study was to determine if increased maternal leptin is followed by changes in body composition, skeletal growth or hormonal regulation in the adult rat offspring. Pregnant rats were given injections of either human recombinant leptin (3.5 mg/kg, i.p.) or vehicle on days 8, 10 and 12 of gestation. Both genders of leptin-exposed offspring showed significantly reduced adipose tIssue weight at adult age. Skeletal growth and cortical bone dimensions were significantly reduced. Circulating testosterone levels were significantly increased in female leptin-exposed offspring, and male leptin-exposed offspring had significant testicular enlargement. No significant effects were seen on circulating leptin levels or hypothalamic protein levels of the leptin receptor. The results demonstrate that maternally administered leptin is involved in fetal growth and development, leading to lean offspring with reduced skeletal growth.


Asunto(s)
Composición Corporal/efectos de los fármacos , Leptina/farmacología , Efectos Tardíos de la Exposición Prenatal , Tejido Adiposo/crecimiento & desarrollo , Animales , Peso Corporal/efectos de los fármacos , Densidad Ósea/efectos de los fármacos , Desarrollo Óseo , Ingestión de Alimentos/efectos de los fármacos , Femenino , Edad Gestacional , Hormonas Esteroides Gonadales/sangre , Leptina/sangre , Masculino , Embarazo , Ratas , Ratas Wistar , Proteínas Recombinantes/farmacología
13.
Biochemistry ; 42(4): 1053-61, 2003 Feb 04.
Artículo en Inglés | MEDLINE | ID: mdl-12549926

RESUMEN

The Zap1 transcriptional activator from Saccharomyces cerevisiae induces expression of a series of genes containing an 11 base pair conserved promoter element (ZRE) under conditions of zinc deficiency. This work shows that Zap1 uses four of its seven zinc finger domains to contact the ZRE and that two of these dominate the interaction by contacting the essential ACC-GGT ends. Two Zn finger domains (ZF1 and ZF2) do not contact DNA, and a third ZF3 may be more important for interfinger protein-protein interactions. Zn finger domains important for ZRE contact were identified from triple mutations in Zap1, changing three residues in the alpha helix in each finger known to be important for DNA contacts in Zn finger proteins. Replacement of -1, 3, and 6 helix residues in ZF4 and ZF7 reduced the affinity of Zap1 for the wild-type ZRE. In contrast, triple mutations within the intervening ZF5 and ZF6 domains had minimal effect. The data argue that fingers 4 and 7 contact the ACC-GGT ends while fingers 5 and 6 contact the 5 bp central ZRE sequence. This conclusion is corroborated by decreased Zap1 affinity for a ZRE DNA duplex containing mutations of the AC-GT ends of the ZRE, whereas transversion mutations within the central 5 bp of the ZRE had minimal effect on Zap1 binding affinity.


Asunto(s)
Proteínas de Unión al ADN/metabolismo , Proteínas de Saccharomyces cerevisiae/metabolismo , Transactivadores/metabolismo , Dedos de Zinc , Secuencias de Aminoácidos/genética , Secuencia de Aminoácidos , Sustitución de Aminoácidos/genética , Animales , Proteínas de Unión al ADN/química , Proteínas de Unión al ADN/genética , Datos de Secuencia Molecular , Mutagénesis Sitio-Dirigida , Unión Proteica/genética , Estructura Secundaria de Proteína/genética , Estructura Terciaria de Proteína/genética , Conejos , Elementos de Respuesta/genética , Proteínas de Saccharomyces cerevisiae/química , Proteínas de Saccharomyces cerevisiae/genética , Resonancia por Plasmón de Superficie , Transactivadores/química , Transactivadores/genética , Factores de Transcripción , Dedos de Zinc/genética
14.
Rev Inst Med Trop Sao Paulo ; 44(2): 79-83, 2002.
Artículo en Inglés | MEDLINE | ID: mdl-12048544

RESUMEN

Leptospirosis severity may be increasing, with pulmonary involvement becoming more frequent. Does this increase result from an intense immune response to leptospire? Notice that renal failure, thrombocytopenia and pulmonary complications are found during the immune phase. Thirty-five hospitalized patients with Weil's disease had 5 blood samples drawn, from the 15th day to the 12th month of symptoms, for ELISA-IgM, -IgG and -IgA specific antibody detection. According their 1st IgG titer, the patients were divided into: group 1 (n = 13) titer > 1:400 (positive) and group 2 (n = 22) titer < or =1:400 (negative). Early IgG antibodies in group 1 showed high avidity which may indicate reinfection. Group 1 was older, had worse pulmonary and renal function, and fever for a longer period than group 2. Throughout the study, IgG and IgA titers remained higher in group 1. In conclusion, the severity of Weil's disease may be associated with the intensity of the humoral immune response to leptospire.


Asunto(s)
Anticuerpos Antibacterianos/inmunología , Afinidad de Anticuerpos/inmunología , Enfermedad de Weil/inmunología , Adolescente , Adulto , Factores de Edad , Anticuerpos Antibacterianos/sangre , Distribución de Chi-Cuadrado , Ensayo de Inmunoadsorción Enzimática , Femenino , Humanos , Inmunoglobulina A/sangre , Inmunoglobulina A/inmunología , Inmunoglobulina G/sangre , Inmunoglobulina G/inmunología , Inmunoglobulina M/sangre , Inmunoglobulina M/inmunología , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Índice de Severidad de la Enfermedad , Estadísticas no Paramétricas
15.
Rev. Inst. Med. Trop. Säo Paulo ; 44(2): 79-83, Mar.-Apr. 2002. graf, tab
Artículo en Inglés | LILACS, Sec. Est. Saúde SP | ID: lil-308010

RESUMEN

Leptospirosis severity may be increasing, with pulmonary involvement becoming more frequent. Does this increase result from an intense immune response to leptospire? Notice that renal failure, thrombocytopenia and pulmonary complications are found during the immune phase. Thirty-five hospitalized patients with Weil's disease had 5 blood samples drawn, from the 15th day to the 12th month of symptoms, for ELISA-IgM, -IgG and -IgA specific antibody detection. According their 1st IgG titer, the patients were divided into: group 1 (n = 13) titer > 1:400 (positive) and group 2 (n = 22) titer <=1:400 (negative). Early IgG antibodies in group 1 showed high avidity which may indicate reinfection. Group 1 was older, had worse pulmonary and renal function, and fever for a longer period than group 2. Throughout the study, IgG and IgA titers remained higher in group 1. In conclusion, the severity of Weil's disease may be associated with the intensity of the humoral immune response to leptospire


Asunto(s)
Humanos , Masculino , Femenino , Adolescente , Adulto , Persona de Mediana Edad , Enfermedad de Weil , Afinidad de Anticuerpos , Formación de Anticuerpos , Índice de Severidad de la Enfermedad , Inmunoglobulina A , Inmunoglobulina G , Ensayo de Inmunoadsorción Enzimática , Distribución de Chi-Cuadrado , Estudios Prospectivos , Factores de Edad , Estadísticas no Paramétricas , Anticuerpos Antivirales
16.
Genome Biol ; 2(10): REVIEWS1028, 2001.
Artículo en Inglés | MEDLINE | ID: mdl-11597338

RESUMEN

Metal ions are essential nutrients, yet they can also be toxic if they over-accumulate. Homeostatic mechanisms and detoxification systems therefore precisely control their intracellular levels and distribution. The tools of functional genomics are rapidly accelerating understanding in this field, particularly in the yeast Saccharomyces cerevisiae.


Asunto(s)
Metales Pesados/metabolismo , Proteínas de Saccharomyces cerevisiae , Saccharomyces cerevisiae/genética , Saccharomyces cerevisiae/metabolismo , Cobre/metabolismo , Proteínas Fúngicas/fisiología , Perfilación de la Expresión Génica , Genoma Bacteriano , Glutatión/biosíntesis , Hierro/metabolismo , Modelos Químicos , ARN Bacteriano/biosíntesis , Regulón , Transactivadores/fisiología , Factores de Transcripción , Zinc/metabolismo
17.
J Biol Chem ; 276(25): 22258-64, 2001 Jun 22.
Artículo en Inglés | MEDLINE | ID: mdl-11301334

RESUMEN

The ZIP superfamily of transporters plays important roles in metal ion uptake in diverse organisms. There are 12 ZIP-encoding genes in humans, and we hypothesize that many of these proteins are zinc transporters. In this study, we addressed the role of one human ZIP gene, hZIP1, in zinc transport. First, we examined (65)Zn uptake activity in K562 erythroleukemia cells overexpressing hZIP1. These cells accumulated more zinc than control cells because of increased zinc influx. Moreover, consistent with its role in zinc uptake, hZIP1 protein was localized to the plasma membrane. Our results also demonstrated that hZIP1 is responsible for the endogenous zinc uptake activity in K562 cells. hZIP1 is expressed in untransfected K562 cells, and the increase in mRNA levels found in hZIP1-overexpressing cells correlated with the increased zinc uptake activity. Furthermore, hZIP1-dependent (65)Zn uptake was biochemically indistinguishable from the endogenous activity. Finally, inhibition of endogenous hZIP1 expression with antisense oligonucleotides caused a marked decrease in endogenous (65)Zn uptake activity. The observation that hZIP1 is the major zinc transporter in K562 cells, coupled with its expression in many normal cell types, indicates that hZIP1 plays an important role in zinc uptake in human tissues.


Asunto(s)
Proteínas Portadoras/metabolismo , Zinc/metabolismo , Secuencia de Bases , Proteínas Portadoras/genética , Proteínas de Transporte de Catión , Cartilla de ADN , Humanos , Células K562 , ARN Mensajero/genética
18.
J Toxicol Environ Health A ; 62(4): 227-41, 2001 Feb 23.
Artículo en Inglés | MEDLINE | ID: mdl-11245393

RESUMEN

Associations were determined between retinol and the thyroid hormones thyroxine (T4) and triiodothyronine (T3), respectively, and the organochlorine contaminants (OCs) polychlorinated biphenyls (PCBs), 1, 1-dichloro-2,2-bis-(4-chlorophenyl)ethylene (DDE), hexachlorobenzene (HCB), and hexachlorocyclohexanes (HCHs) in blood plasma from polar bears (Ursus maritimus) caught at Svalbard. The blood samples were collected from free-ranging polar bears of different age and sex in 1991-1994. The retinol concentration and the ratio of total T4 (TT4) to free T4(FT4) (TT4/FT4 ratio) decreased linearly with increasing concentrations of PCBs and HCB. Retinol was also negatively associated with HCHs, while the TT4/FT4 ratio was positively associated with DDE. The concentrations of retinol and thyroid hormones were significantly higher in females than in males. However, the TT4/FT4 and TT3/FT3 ratios were significantly higher in males than in females. The concentrations of thyroid hormones were negatively correlated with age in male bears, while in females, thyroid hormones did not change with age. The OCs were found to explain 12, 30, and 7% of the variation of retinol concentrations and the TT4/FT4 and TT3/FT3 ratios, respectively, after correcting for age and sex. The potential consequence of these associations for the individual and the population is unknown.


Asunto(s)
Contaminantes Ambientales/sangre , Bifenilos Policlorados/sangre , Tiroxina/sangre , Triyodotironina/sangre , Ursidae/sangre , Vitamina A/sangre , Animales , Femenino , Masculino , Noruega , Embarazo , Reproducción
19.
Biometals ; 14(3-4): 251-70, 2001.
Artículo en Inglés | MEDLINE | ID: mdl-11831460

RESUMEN

The last ten years have witnessed major advances in our understanding of zinc transporters and their regulation in eukaryotic organisms. Two families of transporters, the ZIP (Zrt-, Irt-like Protein) and CDF (Cation Diffusion Facilitator) families, have been found to play a number of important roles in zinc transport. These are ancient gene families that span all phylogenetic levels. The characterized members of each group have been implicated in the transport of metal ions, frequently zinc, across lipid bilayer membranes. This remarkable conservation of function suggests that other, as yet uncharacterized members of the family, will also be involved in metal ion transport. Many of the ZIP family transporters are involved in cellular zinc uptake and at least one member, the Zrt3 transporter of S. cerevisiae, transports stored zinc out of an intracellular compartment during adaptation to zinc deficiency. In contrast, CDF family members mediate zinc efflux out of cells or facilitate zinc transport into intracellular compartments for detoxification and/or storage. The activity of many of these transporters is regulated in response to zinc through transcriptional and post-transcriptional mechanisms to maintain zinc homeostasis at both the cellular and organismal levels.


Asunto(s)
Proteínas Portadoras/genética , Proteínas Portadoras/metabolismo , Zinc/metabolismo , Secuencia de Aminoácidos , Animales , Proteínas Portadoras/química , Proteínas de Transporte de Catión , Secuencia Conservada , Células Eucariotas , Humanos , Transporte Iónico , Mamíferos , Modelos Biológicos , Modelos Moleculares , Datos de Secuencia Molecular , Filogenia , Plantas/genética , Plantas/metabolismo , Procesamiento Proteico-Postraduccional , Saccharomyces cerevisiae/genética , Saccharomyces cerevisiae/metabolismo , Homología de Secuencia de Aminoácido , Transcripción Genética
20.
Biochem J ; 351 Pt 2: 477-84, 2000 Oct 15.
Artículo en Inglés | MEDLINE | ID: mdl-11023834

RESUMEN

The plasma-membrane of Saccharomyces cerevisiae contains high affinity permeases for Cu(I) and Fe(II). A low affinity Fe(II) permease has also been identified, designated Fet4p. A corresponding low affinity copper permease has not been characterized, although yeast cells that lack high affinity copper uptake do accumulate this metal ion. We demonstrate in the present study that Fet4p can function as a low affinity copper permease. Copper is a non-competitive inhibitor of (55)Fe uptake through Fet4p (K(i)=22 microM). Fet4p-dependent (67)Cu uptake was kinetically characterized, with K(m) and V(max) values of 35 microM and 8 pmol of copper/min per 10(6) cells respectively. A fet4-containing strain exhibited no saturable, low affinity copper uptake indicating that this uptake was attributable to Fet4p. Mutant forms of Fet4p that exhibited decreased efficiency in (55/59)Fe uptake were similarly compromised in (67)Cu uptake, indicating that similar amino acid residues in Fet4p contribute to both uptake processes. The copper taken into the cell by Fet4p was metabolized similarly to the copper taken into the cell by the high affinity permease, Ctr1p. This was shown by the Fet4p-dependence of copper activation of Fet3p, the copper oxidase that supports high affinity iron uptake in yeast. Also, copper-transported by Fet4p down-regulated the copper sensitive transcription factor, Mac1p. Whether supplied by Ctr1p or by Fet4p, an intracellular copper concentration of approx. 10 microM caused a 50% reduction in the transcriptional activity of Mac1p. The data suggest that the initial trafficking of newly arrived copper in the yeast cell is independent of the copper uptake pathway involved, and that this copper may be targeted first to a presumably small 'holding' pool prior to its partitioning within the cell.


Asunto(s)
Proteínas Portadoras/fisiología , Proteínas de Transporte de Catión , Cobre/metabolismo , Proteínas de Unión a Hierro , Hierro/metabolismo , Proteínas de la Membrana/fisiología , Proteínas de Saccharomyces cerevisiae , Saccharomyces cerevisiae/enzimología , Transporte Biológico , Proteínas Transportadoras de Cobre , Transportador de Cobre 1 , Relación Dosis-Respuesta a Droga , Regulación hacia Abajo , Activación Enzimática , Galactosa/metabolismo , Glucosa/metabolismo , Iones , Cinética , Proteínas de la Membrana/metabolismo , Proteínas de Transporte de Membrana/metabolismo , Mutación , Transcripción Genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA